Q12879 (NMDE1_HUMAN) Homo sapiens (Human)
Glutamate receptor ionotropic, NMDA 2A UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
22 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Structure of the human GluN1/GluN2A NMDA receptor in the glutamate/glycine-bound state at pH 7.8 |
Heteromer Q05586; | |||||
Assess | ||||||
Structure of the human GluN1-GluN2A NMDA receptor in complex with S-ketamine, glycine and glutamate |
Heteromer Q05586; | 24×NAG; 2×GLY; 2×GLU; 1×JC9; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A NMDA receptor in the glutamate/glycine-bound state at pH 6.3, C… |
Heteromer Q05586; | |||||
Assess | ||||||
Structure of the human GluN1/GluN2A NMDA receptor in the glutamate/glycine-bound state at pH 6.3, C… |
Heteromer Q05586; | |||||
Assess | ||||||
Structure of the human GluN1/GluN2A NMDA receptor in the glutamate/glycine-bound state at pH 6.3, C… |
Heteromer Q05586; | |||||
Assess | ||||||
Structure of the human GluN1/GluN2A NMDA receptor in the glycine/glutamate/GNE-6901/9-AA bound state |
Heteromer Q05586; | 16×NAG; 1×AA; 2×6RM; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A NMDA receptor in the CGP-78608/glutamate bound state |
Heteromer Q05586; | 16×NAG; 2×J86; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A NMDA receptor in the glycine/glutamate/GNE-6901 bound state |
Heteromer Q05586; | 14×NAG; 2×6RM; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A NMDA receptor in the glycine/CPP bound state |
Heteromer Q05586; | 8×NAG; 2×7RC; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A NMDA receptor in the glycine/glutamate bound state |
Heteromer Q05586; | 18×NAG; | ||||
Assess | ||||||
Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4 |
Heteromer Q05586; Q14957; | 4×NAG; 2×NAG; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A LBD in complex with GNE0723 |
Heteromer Q05586; | 1×ACT; 1×GLU; 1×6RV; 1×GLY; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A LBD in complex with GNE6901 |
Heteromer Q05586; | 1×ACT; 1×GLU; 1×GLY; 1×6RM; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A LBD in complex with N-ethyl-7-{[2-fluoro-3-(trifluoromethyl)phe… |
Heteromer Q05586; | 1×CA; 1×GLU; 1×67J; 1×EPE; 1×GLY; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A LBD in complex with GNE3419 |
Heteromer Q05586; | 1×ACT; 1×GLU; 1×CA; 1×GLY; 1×5YC; | ||||
Assess | ||||||
Structure of the apo human GluN1/GluN2A LBD |
Heteromer Q05586; | 6×GOL; 1×GLU; 1×GLY; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A LBD in complex with GNE8324 |
Heteromer Q05586; | 1×ACT; 1×GLU; 1×GLY; 1×5YE; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A LBD in complex with compound 2 (GNE9178) |
Heteromer Q05586; | 1×ACT; 1×GLU; 1×7H0; 1×CA; 1×GLY; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A LBD in complex with compound 9 (GNE3500) |
Heteromer Q05586; | 1×GLU; 1×7H2; 1×GLY; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A LBD in complex with NAM |
Heteromer Q05586; | 1×GLU; 1×5YD; 1×CA; 1×GLY; | ||||
Assess | ||||||
Structure of the human GluN1/GluN2A LBD in complex with 7-{[ethyl(4-fluorophenyl)amino]methyl}-N,2-… |
Heteromer Q05586; | 1×GLU; 1×GLY; 1×67H; | ||||
Assess | ||||||
Crystal structure of the PTPN4 PDZ domain complexed with the C-terminus of the GluN2A NMDA receptor… |
Heteromer P29074; | |||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7eu7.1.B | monomer | 0.66 | 1×GLU; | 100.00 | ||
Assess | ||||||
7ks0.1.D | monomer | 0.51 | 23.20 | |||
Assess |
2 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 7eu7.1.B | monomer | 0.66 | 1×GLU; | 100.00 | |
Assess | ||||||
Isoform 2 | 6whv.1.A | monomer | 0.54 | 26.26 | ||
Assess |